PlainRecalls
FDA Drug Low Class III Terminated

Suprax (cefixime for oral suspension) USP, 100 mg/5 mL, 50 mL bottles (when reconstituted), Manufactured for Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, MD 21202, Manufactured by Lupin Limited Mumbai 400 058 India, NDC 68180-202-03.

Reported: April 24, 2013 Initiated: January 31, 2013 #D-264-2013

Product Description

Suprax (cefixime for oral suspension) USP, 100 mg/5 mL, 50 mL bottles (when reconstituted), Manufactured for Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, MD 21202, Manufactured by Lupin Limited Mumbai 400 058 India, NDC 68180-202-03.

Reason for Recall

Discoloration; Product may not meet specifications for color description once reconstituted.

Details

Units Affected
64,368 bottles
Distribution
Nationwide
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Suprax (cefixime for oral suspension) USP, 100 mg/5 mL, 50 mL bottles (when reconstituted), Manufactured for Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, MD 21202, Manufactured by Lupin Limited Mumbai 400 058 India, NDC 68180-202-03.. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 64,368 bottles.
Why was this product recalled?
Discoloration; Product may not meet specifications for color description once reconstituted.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 24, 2013. Severity: Low. Recall number: D-264-2013.